Autonomix Scientific Decided on for Featured Summary and Podium Presentation of Lengthy-Time period Ache Mitigation in Pancreatic Most cancers at SIR 2026
THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE) -- Autonomix Scientific, Inc. (NASDAQ:…
Silexion Therapeutics Receives Approval from Israeli Ministry of Well being to Begin Section 2/3 Medical Trial of SIL204 in In the community Complex Pancreatic Most cancers
Important regulatory milestone marks development into clinical-stage building of next-generation RNAi remedy…
Silexion Therapeutics Receives Approval from Israeli Ministry of Well being to Begin Segment 2/3 Medical Trial of SIL204 in In the community Complicated Pancreatic Most cancers
Important regulatory milestone marks development into clinical-stage building of next-generation RNAi remedy…
